Service Contract for 22 Heracell 160i Incubators and 2 Steri-Cult Incubators
NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Service Contract for 22 Heracell 160i Incubators and 2 Steri-Cult Incubators (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95019Q00320 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition teshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), NIDA Office of Acquisitions - NCATS Section, on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Thermo Fisher (Asheville) Scientific, LLC, 28 Schenck Pkwy., Ste. 400, Asheville, NC 28803 or an authorized service provider for a service contract for incubators located in the Stem Cell Translation Laboratory (SCTL). Pursuant to FAR Subpart 13.501(a)(1)(iv) the rationale for the brand name justification is that the manufactor's warranty or extended warranty will be voided if any unauthorized service provider not certified by Thermo Fisher Scientific (Asheville) LLC performs a repair on or calibrates a Thermo Fisher incubator. (iii) The solicitation document and incorporated provisions and clauses are those in effect tough Federal Acquisition Circular 2019-05 dated August 13, 2019. (iv) The associated NAICS code is 811219 and the small business size standard is $20,500,000.00. No set-aside restriction is applicable. (v) The SCTL performs tissue culture of iPSCs, which are incubated in water-jacketed CO2 incubators. SCTL purchased 2 incubators for this purpose in 2014 and 22 more in 2017. They are among the most integral parts of the tissue culture process, and by extension, the lab. This equipment must maintain exact levels of CO2, heat, and humidity in order to ensure the proper growth and survival of the cells that are the backbone of the experiments performed in the SCTL. NCATS requires a service contract for all of the incubators in the SCTL to keep the incubators in optimal working condition, ensure proper calibration, provide preventative maintenance, and minimize downtime due to equipment malfunctions. (vi) A comprehensive support plan is needed to service all 24 incubators on site when issues arise, as well as one preventative maintenance visit and any necessary calibration of equipment that is deemed inadequate. All labor, parts, and travel time must be included. Service will be completed within 48 hours of request for on-site service. NCATS will properly maintain instrument, and decontaminate instrument if service requires prior to service call. Access to the instrument during regular business hours will be granted. This requirement is to obtain services completed by an authorized provider to procure maintenance service on existing government-owned laboratory equipment manufactured by and previously purchased from the subject contractor. The authorized provider shall perform a service agreement and preventive maintenance as described herein that must be carried out and performed by authorized Original Equipment Manufacturer (OEM) certified and/or current factory-trained technicians. The period of performance will be effective for 12 months ARO and will include the option to exercise four additional one-year performance periods, per the following: Base Year: 09/27/2019 - 09/26/2020 Option Year 1: 09/27/2020 - 09/26/2021 Option Year 2: 09/27/2021 - 09/26/2022 Option Year 3: 09/27/2022 - 09/26/2023 Option Year 4: 09/27/2023 - 09/26/2024 (vii) Place of Performance: The National Center for Advancing Translational Sciences (NCATS) 9800 Medical Center Drive, Bldg. B Rockville, MD 20850 (viii) The provision at FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition. (ix) Offers will be evaluated for technical criteria, price, and past performance. Technical criteria consist of matching the line items identified above. Technical and past performance, when combined, are significantly more important than price. OR The provision at FAR clause 52.212-2, Evaluation - Commercial Items, applies to this acquisition. (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: (i) technical approach (ii) price (iii) past performance [FAR 13.106-2(b)(3)] Technical and past performance, when combined, are significantly more important than cost or price. (b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s). (c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (x) Offerors are to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with offers. (xi) The FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. The following addendum applies: SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998) This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a clause may be accessed electronically at these addresses: For FAR clauses: https://www.acquisition.gov/browsefar For HHSAR clauses: https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (end of clause) The following FAR provisions or clauses are incorporated by reference: 52.204-7, System for Award Management (Oct 2018) 52.204-13, System for Award Management Maintenance (Oct 2018) 52.204-16, Commercial and Entity Code Reporting (Jul 2016) 52.204-18, Commercial and Entity Code Maintenance (Jul 2016) 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services of Equipment HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015). 52.212-4(g), Invoice, is supplemented by the NIH Invoice and Payment Instructions (2/2014). (xii) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. (xiii) The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. (xiv) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xv) This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the product or service. A determination by the Government whether to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered to determine whether to proceed on a non-competitive basis as indicated above, or to conduct a competitive procurement. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations. Respondents that believe that they are manufacturers or authorized resellers of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. (xvi) In addition, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All responses must be received by September 18, 2019 at 1:00pm, Eastern Standard Time and reference solicitation number 75N95019Q00320. Responses must be submitted by email to Jessica Adams, Contract Specialist at jessica.adams@nih.gov. . 75N95019Q00320 Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences
9/12/19, 11:47 AM Service contract for 22 Heracell 160i incubators and 2 Steri-cult incubators
SOURCES SOUGHT NOTICE 1. Solicitation Number: 75N95019Q00320 2. Title: Service contract for 22 Heracell 160i incubators and 2 Steri-cult incubators 3. NAICS Code: 811219 Other Electronic and Precision Equipment Repair and Mainenance 4. Description: This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement. This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. Background: The Stem Cell Translation Laboratory (SCTL) of the National Center for Advancing Translation Sciences (NCATS) performs tissue culture of iPSCs, which are incubated in water-jacketed CO2 incubators. SCTL purchased 2 incubators for this purpose in 2014, and 22 more in 2017, and they are among the most integral parts of the tissue culture process, and by extension, the lab. This equipment must maintain exact levels of CO2, heat, and humidity in order to ensure the proper growth and survival of the cells that are the backbone of the experiments performed in SCTL. The instruments require a service agreement in place to ensure they remain in proper working order. Purpose and Objectives: NCATS requires a service contract for all of the incubators in the Stem Cell Translation Laboratory to keep them in optimal working condition, ensure proper calibration, provide preventative maintenance, and minimize downtime due to equipment malfunctions. Project requirements: A comprehensive support plan is needed to service all 24 incubators on site when issues arise, as well as one preventative maintenance visit and any necessary calibration of equipment that is deemed inadequate. All labor, parts, and travel time will be included. Service will be completed within 48 hours of request for on-site service. Thermo Fisher Scientific factory trained and certified technicians are required to complete all PM, calibrations, repairs. NCATS will properly maintain instrument, and decontaminate instrument if service requires prior to service call. Access to the instrument during regular business hours will be granted.. Anticipated period of performance: The period of performance will be effective for 12 months ARO and will include the option to exercise four additional one-year performance periods, per the following: - Base Year: 09/27/2019 - 09/26/2020 - Option Year 1: 09/27/2020 - 09/26/2021 - Option Year 2: 09/27/2021 - 09/26/2022 - Option Year 3: 09/27/2022 - 09/26/2023 - Option Year 4: 09/27/2023 - 09/26/2024 Requested Response: The intent of this sources sought notice is to define the procurement strategy (e.g. set-aside, sole source, unrestricted) for a solicitation that NCATS intends to post soon. Interested contractors are requested to respond by (1) identifying how their proposed product meets or exceeds each of the seven salient charactistics listed above, by number; and (2) providing product literature, white papers, or capability statements that demonstrate their bona fide ability to supply such an instrument within the time frame described above. In addition, please state your business size status and whether you are the manufacturer or authorized distributor of the device you propose. Please note that NCATS is particularly interested in small business sources. If you are a small business, please state the type of small business (small business; HUBZone; service-disabled, veteran-owned; 8(a); veteran-owned; woman-owned; or small disadvantaged businesses) and your size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. The respondent must also provide their DUNS number, organization name, address, point of contact, and size and type of business (e.g., 8(a), HubZone, etc., pursuant to the applicable NAICS code and any other information that may be helpful in developing or finalizing the acquisition requirements. The response must include the respondents' technical and administrative points of contact, including names, titles, addresses, telephone and fax numbers, and e-mail addresses. The information submitted must be must be in an outline format that addresses each of the elements of the project requirement. A cover page and an executive summary may be included but is not required. All responses to this notice must be submitted electronically to the Contract Specialist and Contracting Officer. Facsimile responses are NOT accepted. The response must be submitted to Jessica Adams, Contract Specialist at jessica.adams@nih.gov. The response must be received on or before August 21, 2019 at 11:00am, Eastern Standard Time. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). . 75N95019Q00320 Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences
8/16/19, 1:04 PM